These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 15717883

  • 1. A comparison of urinary albumin excretion rate and microalbuminuria in various glucose tolerance subjects.
    Wang XL, Lu JM, Pan CY, Tian H, Li CL.
    Diabet Med; 2005 Mar; 22(3):332-5. PubMed ID: 15717883
    [Abstract] [Full Text] [Related]

  • 2. [A study comparing the prevalence of urinary albumin excretion and microalbuminuria in pre-diabetes subjects].
    Wang XL, Lu JM, Pan CY, Tian H.
    Zhonghua Nei Ke Za Zhi; 2004 Mar; 43(3):170-3. PubMed ID: 15059368
    [Abstract] [Full Text] [Related]

  • 3. [Prevalence and predictors of microalbuminuria in persons with various glucose tolerance levels].
    Huo L, Xu M, Huang HE, Li R, Dai M, Wang JG, Ning G, Li XY.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 25; 87(36):2537-40. PubMed ID: 18067826
    [Abstract] [Full Text] [Related]

  • 4. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH, Hong J, Lü AK, Chen Y, Shen WF, Li XY, Ning G.
    Chin Med J (Engl); 2008 Dec 20; 121(24):2509-16. PubMed ID: 19187587
    [Abstract] [Full Text] [Related]

  • 5. Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure.
    Hoffmann IS, Jimenez E, Cubeddu LX.
    J Hum Hypertens; 2001 Jun 20; 15(6):407-12. PubMed ID: 11439316
    [Abstract] [Full Text] [Related]

  • 6. Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Tapp RJ, Shaw JE, Zimmet PZ, Balkau B, Chadban SJ, Tonkin AM, Welborn TA, Atkins RC.
    Am J Kidney Dis; 2004 Nov 20; 44(5):792-8. PubMed ID: 15492944
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus.
    Hodge AM, Dowse GK, Zimmet PZ.
    Diabet Med; 1996 May 20; 13(5):441-9. PubMed ID: 8737026
    [Abstract] [Full Text] [Related]

  • 9. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M, Karatas M, Sahin M, Ertugrul D, Kulaksizoğlu M, Dogruk A, Gokcel A, Tutuncu NB, Guvener ND, Kutlu M.
    Minerva Endocrinol; 2008 Dec 20; 33(4):289-96. PubMed ID: 18923366
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Microalbuminuria in non-insulin-dependent diabetes.
    Mogensen CE, Damsgaard EM, Frøland A, Nielsen S, de Fine Olivarius N, Schmitz A.
    Clin Nephrol; 1992 Dec 20; 38 Suppl 1():S28-39. PubMed ID: 1295705
    [Abstract] [Full Text] [Related]

  • 12. Post-challenge hyperglycaemia is an independent risk factor for arterial stiffness in Japanese men.
    Ohshita K, Yamane K, Ishida K, Watanabe H, Okubo M, Kohno N.
    Diabet Med; 2004 Jun 20; 21(6):636-9. PubMed ID: 15154954
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A, Schreier L, Galli C, Beresan H, Lopez G, Traversa M, Berg G.
    J Ren Nutr; 2006 Oct 20; 16(4):300-3. PubMed ID: 17046613
    [Abstract] [Full Text] [Related]

  • 14. [Urinary albumin excretion in patients with essential hypertension and impaired glucose tolerance].
    Cymerys M, Miczke A, Bogdański P, Pupek-Musialik D.
    Pol Merkur Lekarski; 2003 Dec 20; 15(90):530-3. PubMed ID: 15058254
    [Abstract] [Full Text] [Related]

  • 15. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP, Hartig M, Cowan PA, Velasquez-Mieyer PA.
    J Am Acad Nurse Pract; 2009 Mar 20; 21(3):173-8. PubMed ID: 19302694
    [Abstract] [Full Text] [Related]

  • 16. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P, Saraç F, Saygili F, Ozgen AG, Yilmaz C, Tüzün M.
    Acta Diabetol; 2008 Sep 20; 45(3):151-6. PubMed ID: 18496644
    [Abstract] [Full Text] [Related]

  • 17. Change in prevalence and 6-year incidence of diabetes and impaired fasting glucose in Korean subjects living in a rural area.
    Song KH, Nam-Goomg IS, Han SM, Kim MS, Lee EJ, Lee YS, Lee MS, Yoon S, Lee KU, Park JY.
    Diabetes Res Clin Pract; 2007 Dec 20; 78(3):378-84. PubMed ID: 17544540
    [Abstract] [Full Text] [Related]

  • 18. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
    Ko GT, Cockram CS, Chan JC.
    J Med; 2001 Dec 20; 32(1-2):53-65. PubMed ID: 11321888
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown.
    Lu B, Wen J, Song XY, Dong XH, Yang YH, Zhang ZY, Zhao NQ, Ye HY, Mou B, Chen FL, Liu Y, Shen Y, Wang XC, Zhou LN, Li YM, Zhu XX, Hu RM.
    Diabetes Res Clin Pract; 2007 Feb 20; 75(2):184-92. PubMed ID: 16893584
    [Abstract] [Full Text] [Related]

  • 20. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A, Siemińska J, Górnicka B, Ziarkiewicz-Wróblewska B, Ziółkowski B, Muszyński J.
    Scand J Gastroenterol; 2006 Sep 20; 41(9):1079-86. PubMed ID: 16938722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.